Referred to the House Committee on Energy and Commerce.
This bill bars the impoundment, transfer, or reprogramming of discretionary appropriations made available for the National Institutes of Health (NIH) unless a new law, enacted after this Act and expressly referencing it, authorizes the change. It also requires the HHS Secretary to certify within 30 days and annually to relevant House and Senate committees that HHS and the NIH Director comply with the Act's requirements.
Progressives emphasize research stability and anti-politicization
Relative to its intended legislative type, this bill succinctly creates a substantive legal constraint on the impoundment, transfer, or reprogramming of NIH discretionary funds and adds an annual certification requirement.
This bill bars the impoundment, transfer, or reprogramming of discretionary appropriations made available for the National Institutes of Health (NIH) unless a new law, enacted after this Act and expressly referencing it, authorizes the change.
It also requires the HHS Secretary to certify within 30 days and annually to relevant House and Senate committees that HHS and the NIH Director comply with the Act's requirements.
Modest-to-strong chance because it is narrow, non‑fiscal, and protects popular NIH funding, but executive flexibility concerns and Senate process reduce certainty.
Relative to its intended legislative type, this bill succinctly creates a substantive legal constraint on the impoundment, transfer, or reprogramming of NIH discretionary funds and adds an annual certification requirement. The core prohibition and the reporting duty are clearly stated but the text is spare on definitions, enforcement, fiscal implications, and interaction with other authorities.
Progressives emphasize research stability and anti-politicization
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize research stability and anti-politicization
Likely supportive.
The bill protects NIH funding stability, which advances long-term medical research and public-health projects.
It prevents executive or agency-level diversion of research dollars without explicit congressional approval.
Generally favorable but cautious.
The bill improves funding predictability and congressional oversight, yet it also risks constraining executive flexibility for urgent responses.
Would seek balanced safeguards and clear procedures.
Mixed to skeptical.
Some conservatives will welcome limits on executive impoundment, but many will object to further entrenching a major discretionary program and reducing administrative flexibility to manage funds.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Modest-to-strong chance because it is narrow, non‑fiscal, and protects popular NIH funding, but executive flexibility concerns and Senate process reduce certainty.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize research stability and anti-politicization
Modest-to-strong chance because it is narrow, non‑fiscal, and protects popular NIH funding, but executive flexibility concerns and Senate p…
Relative to its intended legislative type, this bill succinctly creates a substantive legal constraint on the impoundment, transfer, or reprogramming of NIH discretionary funds and adds an annual certification requireme…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.